Article

Pharmacogenetics of antipsychotic-induced side effects

2009-12-31

Abstract excerpt

Currently available antipsychotic drugs (APDs) carry significant, though highly variable, liability to neurologic and metabolic side effects. Pharmacogenetics approaches offer the possibility of identifying patient-specific biomarkers for predicting risk of these side effects. To date, a few single nucleotide polymorphisms (SNPs) in a handful of genes have received convergent support across multiple studies. The p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 79efd037-8f34-58f2-bb7b-baaa2b563d87
DOI: 10.31887/dcns.2009.11.4/tlencz

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of antipsychotic-induced side effectsDOI 10.31887/dcns.2009.11.4/tlenczRead

Pharmacogenetics of antipsychotic-induced side effects.Semantic proximity Read

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read

Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.Semantic proximity Read

Pharmacogenetics of AntipsychoticsSemantic proximity Read

The pharmacogenetics of antipsychotic-induced adverse events.Semantic proximity Read

Pharmacogenetics-Guided Advances in Antipsychotic Treatment.Semantic proximity Read

Pharmacogenetics of second-generation antipsychotics.Semantic proximity Read

The pharmacogenetics of antipsychotic treatment.Semantic proximity Read

New findings in pharmacogenetics of schizophreniaSemantic proximity Read

Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.Semantic proximity Read

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read

Pharmacogenetics of Clinical Response to RisperioneSemantic proximity Read